Alkem Foundation and IIT Bombay are collaborating to establish a research center for immuno-therapeutics and regenerative medicines. The Alkem Centre will be funded by the Alkem Foundation, contributing 20-25% of its cumulative CSR obligations over seven years. The aim is to foster innovation and address unmet medical needs through cutting-edge research.
Strategic Partnership Announced
Alkem Foundation and IIT Bombay have announced a strategic collaboration to establish a research center dedicated to immuno-therapeutics and regenerative medicines. The partnership aims to advance research and innovation in complex disease areas with unmet medical needs. The announcement was made on November 3, 2025.
Details of the Collaboration
The Alkem Foundation will fund the establishment of the “Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines” at IIT Bombay. This collaboration will foster cutting-edge research and innovation. Alkem Foundation will contribute 20-25% of its cumulative CSR obligations over seven years to the research center.
Focus and Objectives
The research center will focus on building an ecosystem that enables innovation, research, and skill development. This includes bridging gaps in infrastructure, talent, and translational capability, especially in the area of high precision medicines. The initiative will integrate biology, engineering, and data science to advance human health.
Statements from Leadership
Mrs. Madhurima Singh, Executive Director and Chairperson of the CSR and Sustainability Committee, Alkem, stated that Alkem understands the critical role of scientific advancement and transformative research in addressing unmet medical needs.
Prof. Shireesh B. Kedare, Director, IIT Bombay, said that IIT Bombay’s strong foundation will help translate cutting-edge research into healthcare impact.
Source: BSE
